| Literature DB >> 27446107 |
Amy L Jancewicz1, Nicole M Gibbs2, Patrick H Masson3.
Abstract
Cadaverine derives from lysine in a pathway that is distinct from that of the other well-characterized ornithine- or arginine-derived polyamines. Despite a multitude of studies in bacterial systems, cadaverine has garnered little attention in plant research. Nonetheless, many plants have been found to synthesize it. For instance, the Leguminosae have been shown to produce cadaverine and use it as a precursor in the biosynthesis of quinolizidine alkaloids, secondary metabolites that are involved in insect defense and also display therapeutic pharmacological properties. Cadaverine is also present in the environment; it can be produced by rhizosphere and phyllosphere microbes. Markedly, exogenous cadaverine application causes alterations in root-system architecture. Previous research suggests cadaverine has a role in stress response, with groups reporting an increase in content upon exposure to heat, drought, salt, and oxidative stress. However, data regarding the role of cadaverine in stress response remains conflicted, as some plant systems show enhanced tolerance to stresses in its presence, while others show increased sensitivity to the same stresses. In this review, we summarize recent findings on the role of cadaverine in plant growth, development, and stress response. We also address the possible roles rhizosphere and phyllosphere microbes may play in the delivery of exogenous cadaverine near plant organs, and discuss our current understanding of the molecular pathways that contribute to cadaverine homeostasis and response in plants.Entities:
Keywords: cadaverine; metabolism; phyllosphere; plant development; polyamine; rhizosphere; root architecture; stress response
Year: 2016 PMID: 27446107 PMCID: PMC4914950 DOI: 10.3389/fpls.2016.00870
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Exogenous application of cadaverine induces morphological changes.
| Species | Treatment conditions | Result of cad treatment | [Cad] | Percent change |
|---|---|---|---|---|
| Germinated and grown on Cad for 2 weeks | Primary root growth inhibition | 2 mM | Not quantified | |
| Germinated and grown on Cad for 6 days | Primary root growth inhibition | 100 μμM | 2–65%* | |
| 500 μM | 25–70%* | |||
| Change in lateral root branching | 100 μM | -20–630%* | ||
| 500 μM | 5–850%* | |||
| Change in horizontal growth index | 100 μM | 10–70%* | ||
| 500 μM | 30–70%* | |||
| Change in straightness | 100 μM | -2–10%* | ||
| 500 μM | -10–20%* | |||
| Sown on filter paper with Cad solution | Increased germination after 24 h | 1 mM | 5%* | |
| Watered with Cad solution for 7 days | Decreased fresh weight | 1 mM | 15%* | |
| Germinated and grown on Cad for 5 days | Enhanced lateral root development | 1 mM | Not quantified | |
| Germinated on soil and watered with Cad for 7 days | Hypocotyl elongation | 25 μM | 30% * | |
| 50 μM | 40%* | |||
| 100 μM | 20%* | |||
| Germinated and grown on Cad for 7 days | Increased coleoptile length | 10 μM | 21% | |
| Increased fresh weight | 10 μM | 4% | ||
| Increased radicle number | 10 μM | 25% | ||
| Cad pretreatment for 7 days then moved to soil until day 20 | Increase in adaxial epidermis cells number | 10 μM | 34% | |
| Increase in abaxial epidermis cells number | 10 μM | 27% | ||
| Increased distance between vascular bundles | 10 μM | 10% | ||
| Increase in stomatal length | 10 μM | 27% | ||
| Increased stomatal width of the abaxial leaf | 10 μM | 3% | ||
| Cad applied on leaf surface of 2 day-old seedlings and grown for 7 days after treatment | Increased root fresh weight | 1 nM | 33%*B | |
| 1 μM | 44%*B | |||
| Increased shoot fresh weight | 1 nM | 24%*B | ||
| 1 μM | 22%*B | |||
| Increased root dry weight | 1 nM | 29%*B | ||
| 1 μM | 30%*B | |||
| Increased shoot dry weight | 1 nM | 14%*B | ||
| 1 μM | 22%*B | |||
| Hypocotyl cuttings from 17 day old seedlings cultured 4 weeks in Cad | Decrease in root formation | 500 μM | 10%*C | |
| Guard cell protoplasts from 3 week old plants treated with Cad | Inhibition of potassium influx | 1 mM | 37%* | |
| Decrease in stomatal pore size | 1 mM | 71%* |